Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • BND vs GSK✓SelectedUSD · GSKBND vs GSK performance historyLatest closeAs of+0.09%11/16
Stock and ETF performance explorer

BND vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+17.2%
GSK return
+107.3%
Excess return
-90.1%
Maximum drawdown
-18.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.1%-0.1%+0.2%+0.1%
7D-1.4%-1.3%-0.1%-1.3%
30D+0.1%+2.7%-2.7%0.0%
3M-1.3%+2.7%-4.0%-1.4%
6M-0.9%+3.3%-4.2%-1.1%
YTD-1.4%+6.5%-7.8%-1.7%
1Y-0.8%+10.7%-11.5%-1.3%
3Y+12.3%+64.4%-52.1%+9.8%
5Y-1.3%+46.7%-48.0%-3.5%
10Y+17.2%+109.4%-92.2%+13.3%
All+17.2%+107.3%-90.1%+13.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling